Ушбу иш иқтибос қилган ишлар

15 та иш

Иш: SELECTIVE N-AROYLATION AND N-ARYLSULFONYLATION OF BENZOXAZOLIN-2-ONES

A short history ofSHELX
George M. Sheldrick
Мақола2007203 иқтибос
ABI
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Imran Ali, Mohammad Lone, Zeid A. ALOthman +2
Шарҳ мақола20153 иқтибос
ABI
Oxazole-Based Compounds As Anticancer Agents
Maria Assunta Chiacchio, Giuseppe Lanza, Ugo Chiacchio +4
Шарҳ мақола20183 иқтибос
ABI
Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases
Sham M. Sondhi, Nirupma Singh, Ashok Kumar +2
Мақола20063 иқтибос
ABI
Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery
Adileh Ayati, Saeed Emami, Ali Asadipour +2
Шарҳ мақола20152 иқтибос
ABI
Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1
Francesca Curreli, Spreeha Choudhury, Ilya Pyatkin +6
Мақола20122 иқтибос
ABI
Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-one Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)
Stefania Aiello, Geoffrey Wells, Erica L. Stone +7
Мақола20082 иқтибос
ABI
In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives
Parameshwar Makam, Prasoon Kumar Thakur, Tharanikkarasu Kannan
Мақола20132 иқтибос
ABI
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Koki Kato, Keisuke Hirai, Keiji Nishiyama +6
Мақола20042 иқтибос
ABI
Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists
Osamu Uchikawa, K. Fukatsu, Ryosuke Tokunoh +9
Мақола20022 иқтибос
ABI
Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones
Chung‐Kyu Ryu, Ra-Young Lee, Na Young Kim +2
Мақола20092 иқтибос
ABI
An expeditious synthesis and anticancer activity of novel 4-(3′-indolyl)oxazoles
Dalip Kumar, Nikhil Kumar, Swapna Sundaree +2
Мақола20092 иқтибос
ABI
2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies
Parameshwar Makam, Kankanala Ramakrishna, Amresh Prakash +1
Мақола20132 иқтибос
ABI
Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues
Barbara Parrino, Alessandro Attanzio, Virginia Spanò +7
Мақола20172 иқтибос
ABI
Intrinsic drug potential of oxazolo[5,4‐d]pyrimidines and oxazolo[4,5‐d]pyrimidines
Victor Zhirnov, Yevheniia Velihina, Oleg P. Mitiukhin +1
Шарҳ мақола20212 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

A short history of<i>SHELX</i>

Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

Oxazole-Based Compounds As Anticancer Agents

Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases

Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery

Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1

Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-one Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists

Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones

An expeditious synthesis and anticancer activity of novel 4-(3′-indolyl)oxazoles

2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies

Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues

Intrinsic drug potential of oxazolo[5,4‐<i>d</i>]pyrimidines and oxazolo[4,5‐<i>d</i>]pyrimidines